Please login to the form below

Therapeutic vaccines

This page shows the latest Therapeutic vaccines news and features for those working in and with pharma, biotech and healthcare.

GSK agrees on 10% equity stake in mRNA specialist CureVac

collaboration focused on the development of mRNA-based vaccines and monoclonal antibodies (mAbs). ... The hope is that by using mRNA technology to develop vaccines and therapeutic treatments, specific proteins and antigens can be produced by the body’s

Latest news

J&J catches up to Merck, files Ebola vaccine in Europe

said Johan Van Hoof, global therapeutic area head, vaccines and managing director, Janssen vaccines &prevention. ... Meanwhile, J&J and Merck are now looking to gain official regulatory approvals for their Ebola vaccines with global healthcare agencies.
Bayer takes control of BlueRock stem cell joint venture

In April, Leaps by Bayer made an undisclosed investment in US-based biotech Khloris Biosciences, which specialises in using iPSCs as prophylactic and therapeutic vaccines, using them as a vehicle to
AMR research 'under threat' due to lack of economic incentives

The AMR Industry Alliance said urgent action is needed to address economic challenges to R&D in areas such as antibiotics, vaccines, diagnostics and therapeutic agents.
Immunotherapy and future directions in oncology

New therapeutic cancer vaccines. Recently, a new type of cancer therapeutics entered the market to counter these limitations and provide better treatment outcomes. ... Therapeutic cancer vaccines effectively teach the patient's immune system to recognise
GSK and Novartis asset swap: a tale of two companies

Meanwhile, Novartis will gain nearly all of GSK's cancer drugs, excluding therapeutic vaccines. ... Vaccines are steady growers, but do not create the sort of increase that come from top oncology products.

More from news
Approximately 0 fully matching, plus 25 partially matching documents found.

Latest Intelligence

Biotech profile: Tom Evans, CEO, Vaccitech.

You have a broad pipeline of candidates, including therapeutic vaccines, such as your vaccine for prostate cancer in phase 1. ... How big a role do you think therapeutic vaccines will play in future cancer treatment?
Cancer immunotherapy: What's on the horizon?

Researchers are now trying to identify biomarker-based subgroups and drug combinations to try to improve therapeutic outcomes for patients. ... Vaccines. While the first therapeutic cancer vaccines have reached the market, eg Dendreon’s Provenge and
Deal Watch table for January 2015

Exclusive licence. 522. AC Immune/ Janssen. To develop and commercialise therapeutic anti-Tau vaccines [ACI35, P1] for the treatment of Alzheimer's disease. ... 3 year research collaboration and exclusive licence. 509. Neuropore Therapies/UCB. To develop
Pharma deals during July 2014

The deal brings to Mylan a portfolio of over 100 specialty and branded generic products in five major therapeutic areas (cardio-metabolic, gastrointestinal, anti-infective/respiratory, CNS/pain and women's ... Baxter forecasts that its revenues from

More from intelligence
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest appointments

Neon Therapeutics taps Dr Richard Gaynor for R&D leadership role

At Cambridge, US-based Neon he will be tasked with guiding the immuno-oncology company's research programmes, which are focused on developing neoantigen-based therapeutic vaccines and T cell therapies.
Bionor names executive management team additions

Together, they bring a wealth of experience to advance therapeutic vaccines for Bionor, and specifically will add operational strength to get our HIV functional cure approach advanced to patients and the

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping: Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much: Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website: You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...